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Oral feeding competency is a major determinant of length of stay in the neonatal inten-
sive care unit. An infant must be able to consistently demonstrate the ability to take all 
required enteral nutrition by mouth before discharge home. Most infants born prema-
turely (<37 weeks) will require days, if not weeks, to master this oral feeding competency 
skill. Inappropriately timed feeding attempts can lead to acute and long-term morbidities, 
prolonged hospitalizations, and increased health-care costs. Previously, a panel of five 
genes involved in essential developmental pathways including sensory integration 
(nephronophthisis 4, Plexin A1), hunger signaling [neuropeptide Y2 receptor (NPY2R), 
adenosine-monophosphate-activated protein kinase (AMPK)], and facial development 
(wingless-type MMTV integration site family, member 3) required for oral feeding success 
were identified in neonatal saliva. This study aimed to translate these five transcriptomic 
biomarkers into a rapid proteomic platform to provide objective, real-time assessment of 
oral feeding skills, to better inform care, and to improve neonatal outcomes. Total protein 
was extracted from saliva of 10 feeding-successful and 10 feeding-unsuccessful infants 
matched for age, sex, and post-conceptional age. Development of immunoassays was 
attempted for five oral feeding biomarkers and two reference biomarkers (GAPDH and 
YWHAZ) to normalize for starting protein concentrations. Normalized protein concentra-
tions were correlated to both feeding status at time of sample collection and previously 
described gene expression profiles. Only the reference proteins and those involved in 
hunger signaling were detected in neonatal saliva at measurable levels. Expression 
patterns for NPY2R and AMPK correlated with the gene expression patterns previously 
seen between successful and unsuccessful feeders and predicted feeding outcome. 
Salivary proteins associated with hunger signaling are readily quantifiable in neonatal 
saliva and may be utilized to assess oral feeding readiness in the newborn. This study 
lays the foundation for the development of an informative, rapid, proteomic platform to 
assess neonatal oral feeding maturation.
Keywords: protein, biomarker, saliva, adenosine-monophosphate-activated protein kinase, neuropeptide Y2 
receptor
Table 1 | Patient demographics.
Feeder sex Post-
conceptional 
age (Pca)
gestational 
age (ga)
non-
feeder
sex Pca ga
1 F 39 2/7 37 0/7 1 F 38 5/7 38 2/7
2 F 33 4/7 32 1/7 2 F 32 6/7 32 2/7
3 F 37 2/7 34 0/7 3 F 37 0/7 36 2/7
4 F 34 4/7 33 4/7 4 F 34 2/7 33 1/7
5 F 35 1/7 32 5/7 5 F 35 2/7 33 5/7
6 M 35 2/7 31 5/7 6 M 34 6/7 34 1/7
7 M 37 2/7 36 6/7 7 M 34 1/7 33 0/7
8 M 35 0/7 33 1/7 8 M 34 3/7 32 6/7
9 M 39 2/7 37 4/7 9 M 39 1/7 37 6/7
10 M 35 3/7 34 5/7 10 M 34 6/7 33 0/7
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inTrODUcTiOn
Although oral feeding competency is a discharge requirement 
from the neonatal intensive care unit (NICU), there is currently 
a paucity of objective assessment tools to determine oral feed-
ing maturity in this population (1, 2). Rather, standard of care 
is largely limited to subjective assessment of an infant’s feeding 
cues (i.e., ability to suck on a pacifier) once an infant corrects to 
>32 weeks’ post-conceptional age (PCA) and has a stable respira-
tory status (3–6). The absence of an objective assessment tool to 
determine oral feeding readiness has not only placed immature 
oral feeders at risk for significant feeding associated morbidities, 
including choking, poor growth, impaired short- and long-term 
neurodevelopmental outcomes, and feeding aversions, but it has 
also resulted in prolonged hospitalization, increased health-care 
costs, and parental anxiety (7–11).
Previously, salivary gene expression analyses on hundreds 
of premature infants at both pre- and post-oral feeding success, 
identified five genes involved in oral feeding maturity that were 
differentially expressed between successful and unsuccessful 
oral feeders (12). These genes included Plexin A1 (PLXNA1), 
neuropeptide Y2 receptor (NPY2R), adenosine-monophosphate-
activated protein kinase (AMPK), wingless-type MMTV integra-
tion site family, member 3 (WNT3), and nephronophthisis 4 
(NPHP4). While this prior study demonstrated the feasibility of 
utilizing saliva as a non-invasive biofluid to detect transcriptomic 
biomarkers associated with neonatal developmental milestones, 
the ability to monitor these markers in a timely manner to inform 
care remains a challenge. Proteins have numerous benefits over 
mRNA transcripts including their relative abundance and stabil-
ity (13). Combined with their relative ease for detection and 
quantification compared to genes, proteins are more appealing 
for the development of a rapid salivary diagnostic platform. This 
study aimed to translate the previously described gene expression 
panel to a salivary proteomic platform to rapidly and objectively 
assess oral feeding readiness to limit neonatal morbidities and 
improve outcomes.
MaTerials anD MeThODs
infant recruitment and saliva collection
This study was approved by the Tufts Medical Center Institutional 
Review Board. Parents of premature infants ranging from 33 to 
39 weeks’ PCA were informed about the study and provided writ-
ten consent before enrollment. The Tufts Medical Center NICU 
utilizes the cue-based feeding assessment protocol of Ludwig 
and Waitzman (14). In accordance to this protocol, infants with 
a stable respiratory status and PCA of >32 weeks were assessed 
for feeding capability as part of their routine vital signs by the 
nursing staff. This cue-based feeding assessment protocol scores 
infants from 1 to 5 (1 signifies oral feeding ready and 5 signifies 
no oral feeding cues present). Infants who demonstrate a score 
ranging from 1 to 2 consecutively for three assessment points 
are allowed to attempt oral feeds. No infant less than 32 weeks’ 
PCA was offered oral feeding in the NICU, thus, saliva was not 
collected until the infant was mature enough to attempt oral feeds 
(e.g., >32  weeks’ PCA). Saliva samples were collected equally 
from successful (n = 10) and unsuccessful (n = 10) oral feeders 
at a single time-point. Unsuccessful oral feeders, termed “non-
feeders,” took <50% of feeds by mouth; successful oral feeders, 
termed “feeders,” took full (100%) oral feeds. The <50% of feeds 
by mouth cutoff was utilized to ensure that extraneous factors 
(e.g., nursing staff ratios or acute medical emergencies that may 
have prohibited an oral feeding session for the infant) did not 
contribute to an infant’s designated feeding status. Only those 
infants who consistently demonstrated an oral intake of <50% 
of full enteral nutrition were deemed unsuccessful oral feeders. 
The infants from both cohorts were matched for sex, gestational 
age (GA), PCA at time of sample collection, and ethnicity to limit 
the potential confounding effects of these variables on protein 
expression (Table 1).
Two saliva samples were collected for protein analysis from a 
single time-point in all subjects. Salivary protein was collected, 
stabilized, and extracted from each sample using established pro-
tocols (15). Final elution volume following extraction was 250 µl, 
making it necessary to collect two samples from each infant to 
have sufficient volumes for downstream experiments (required 
volume: 120 µl per biomarker). Total protein extracted from the 
salivary samples was stored at −80°C pending analysis.
Development of rapid Proteomic Platform
Immunoassays were used to measure target protein molecules 
in a sample. These assays were based on the specific recognition 
of target molecules by both capture and detection antibodies. 
For detection of proteins, the sandwich format was used due to 
its high specificity and ability to analyze biofluids in complex 
matrices (16). For protein immunoassays, antibody pairs and 
recombinant protein standards were utilized. In brief, capture 
antibodies were immobilized on microspheres that could be 
suspended in solution. The microspheres were incubated for 
40  min with the sample to allow for protein-specific antibody 
binding. Subsequently, detection antibody was added to the solu-
tion that then bound to another epitope on the target protein. 
The microspheres were washed and then incubated for 20 min 
with 2.5  µg/ml of a streptavidin−phycoerythrin conjugate 
(Columbia Biosciences) to generate the fluorescent complex. 
After a final wash and resuspension in 75  µl phosphate buffer 
FigUre 1 | Calibration curves for eight bulk assays for salivary neonatal 
biomarkers. Serial dilutions of recombinant protein standards for adenosine-
monophosphate-activated protein kinase (AMPK) and neuropeptide Y2 
receptor (NPY2R) were run on all plates for feeder and non-feeder infant 
samples. Error bars depict the SDs for the values as they were all run in 
triplicate.
Table 2 | Assay overviews.
Protein assay 
developed
Protein 
detected
Neuropeptide Y2 receptor Y Y
Adenosine-monophosphate-activated protein kinase Y Y
Plexin A1 N N
Nephronophthisis 4 N N
Wingless-type MMTV integration site family,  
member 3
Y N
GAPDH Y Y
YWHAZ Y Y
FigUre 2 | Raw protein expression levels for salivary neonatal biomarkers. 
Saliva samples from 10 feeders and 10 non-feeders were run using bulk 
immunoassays for adenosine-monophosphate-activated protein kinase 
(AMPK), GAPDH, neuropeptide Y2 receptor (NPY2R), and YWHAZ. Salivary 
protein concentrations (pM) were calculated using the calibration curves and 
plotted. The wide variation observed in protein expression of reference 
biomarkers GAPDH and YWHAZ signify varying protein input between 
samples.
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saline tween-20, the assay results were evaluated on the Tecan 
Infinite M200 Plate Reader platform. Serial dilutions of recom-
binant protein standards for all biomarkers were run to generate 
calibration curves and to determine assay sensitivity, antibody 
performance, and protein detection range. In addition, salivary 
sample dilution series and spike-in and recovery experiments 
were run for all developed assays to exclude non-specific binding 
and to determine the effect of the saliva matrix on the proteins. 
Manufacturer’s details and catalog numbers for all antibodies and 
recombinant protein standards used are provided in Table S1 in 
Supplementary Material.
Testing of rapid Proteomic Platform
Sandwich assays were performed for the detection of protein 
biomarkers in neonatal saliva as described earlier. Alongside the 
recombinant protein standards’ assays, the microspheres were 
also incubated with neonatal saliva samples obtained from feed-
ers and non-feeders. The fluorescence intensity for all samples 
was measured on the Tecan Infinite M200 Plate Reader, and their 
protein concentrations were determined based on the calibration 
curves on the same plates.
Data analysis
GraphPad Prism was used to generate calibration curves for 
all biomarkers. These curves were fit using a 4PL fit with 1/y2 
weighting factor. The calibration curves were used to determine 
concentrations of all protein biomarkers from the neonatal saliva 
samples. GAPDH and YWHAZ were used as reference proteins 
to normalize varying neonatal salivary protein concentrations 
and serve as quality control indices. Detection of both reference 
proteins was required for a sample to be considered in our analy-
sis (17–19). Samples were normalized for comparative analysis 
with the use of the geometric mean (GM) of the two reference 
protein concentrations, using the following formula (example 
shown below is for AMPK):
 ∆AMPK AMPK GM GAPDH YWHAZ [ ].n n n n( ) ( ) ( ) ( )= / +  
resUlTs
Immunoassays were successfully developed for five of the seven 
biomarkers: AMPK, NPY2R, WNT3, GAPDH, and YWHAZ. No 
compatible antibody pairs were found for NPHP4 and PLXNA1. 
Assay development for all biomarkers is summarized in Table 2. 
Results for salivary sample dilution series and spike-in and recov-
ery experiments are summarized in Table S2 in Supplementary 
Material. Calibration curves for all assays are shown in Figure 1. 
Raw and normalized data are depicted in Figures  2 and 3, 
respectively.
All neonatal saliva samples met quality control as defined 
by detection of both reference proteins in a sample. Subject 
demographics and pertinent clinical data are summarized in 
Table 1. Protein levels of both AMPK and NPYR mirrored the 
gene expression profiles reported previously. Namely, AMPK was 
either undetectable (n = 6) or decreased (n = 4) in unsuccessful 
oral feeders, while expression levels of NYP2R were increased 
in unsuccessful oral feeders (n =  10). Median concentrations 
for AMPK and NPY2R in 20 neonatal saliva samples split by 
Table 3 | Median concentrations (pM) of the two measured biomarkers in 20 
neonatal saliva samples split by feeders and non-feeders.
biomarkers adenosine-
monophosphate-
activated protein 
kinase (aMPK) 
(feeders)
aMPK 
(non-
feeders)
neuropeptide 
Y2 receptor 
(nPY2r) 
(feeders)
nPY2r 
(non-
feeders)
Median (pM) 510 271 31.95 415
Detectable 
samples
10/10 4/10 10/10 10/10
FigUre 3 | Normalized protein expression levels for salivary neonatal 
biomarkers. The protein concentrations present in the clinical samples for 
adenosine-monophosphate-activated protein kinase (AMPK) and 
neuropeptide Y2 receptor (NPY2R) were normalized against GAPDH and 
YWHAZ and plotted for all 10 feeders and all 10 non-feeders.
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feeders and non-feeders are summarized in Table 3. WNT3 was 
undetectable in the neonatal saliva samples analyzed.
DiscUssiOn
The transcriptome and proteome, unlike the genome, provide 
insight into biological function and phenotype. Transcription 
and translation are complex mechanisms consisting of stochastic 
expression levels of RNA and protein over time. Numerous stud-
ies have shown that there is not a direct correlation between the 
levels of mRNA and protein (20–23). However, to date, no study 
has used transcriptomic information as a guide for determining 
whether or not proteins are expressed. Using information from 
the neonatal salivary transcriptome, we hypothesized not only 
that the same proteins would be present and correlate with 
mRNA expression levels but also that this information would 
advance our understanding of the dynamic relationship between 
the transcriptome and the proteome in the developing premature 
newborn.
Previously, we identified five key regulatory genes responsi-
ble for oral feeding maturity that were differentially expressed 
between successful and unsuccessful oral feeders, including 
NPY2R, AMPK, PLXNA1, NPHP4, and WNT3 (12). In this prior 
work, each biomarker was expressed in a binary fashion (i.e., it 
was either present or absent as ascertained by amplification). 
With mRNA expression, an infant demonstrated a mature oral 
feeding pattern when AMPK, PLXNA1, and NPHP4 were present, 
and when NPY2R and WNT3 were absent in neonatal saliva. 
Using these data, we hypothesized that the protein expression for 
these targets would parallel their gene expression and allow for 
translation to a more rapid proteomic bedside assay platform to 
assess oral feeding readiness.
A rapid proteomic bedside platform for assessing oral feeding 
readiness has the potential to limit hospital length of stay and 
dramatically reduce health-care costs. Two specific groups of 
neonates, in particular, may largely benefit from such a diag-
nostic assay. First, utilizing this assay to identify neonates with 
mature oral feeding skills, in a timely fashion, who could begin 
oral feeding trials without the fear of deleterious side effects, 
would likely reduce hospital length of stay. Second, this assay 
could be utilized to understand the developmental pathways 
limiting oral feeding success in infants who struggle to orally 
feed despite an advancing PCA. This approach would allow car-
egivers to personalize care plans based specifically on an infant’s 
salivary profile. Here too, there is an important opportunity to 
expedite oral feeding maturation and reduce time spent in the 
NICU. With average NICU costs at $3500 per day in the US, suc-
cessful development of this rapid $5 assay to assess oral feeding 
maturation may result in health-care cost savings of billions of 
dollars per year.
In this pilot study, assays were successfully developed for 
five of the seven biomarkers including AMPK, NPY2R, WNT3, 
GAPDH, and YWHAZ. We were unable to develop protein-based 
assays for all the biomarkers previously identified because of a 
lack of suitable binding reagents for all the proteins. When these 
five immunoassays were carried out on newborn saliva, only 
the two reference biomarkers (GAPDH and YWHAZ) and the 
two proteins involved in hunger signaling (NPY2R and AMPK) 
were detectable. WNT3, associated with facial development, was 
undetectable. Each of the two detectable proteins paralleled the 
gene expression results previously described. In contrast to the 
gene expression levels, where the biomarkers were informative 
in a binary fashion, proteins could be measured at levels such 
that we could quantify them. This discrepancy may be due to 
each respective assay’s detection limit or because of differences 
between mRNA expression levels and protein abundance in 
neonatal saliva. The biological significance of this finding is 
unknown.
Of the three proteomic biomarkers assessed in this study, only 
those involved in hunger signaling were readily detectable in neo-
natal saliva. Their presence suggests not only that they may play 
an important role in regulating feeding behavior in the newborn 
but also implies that protein levels in saliva may be required for 
a maturing gut–brain axis necessary for successful oral feeding. 
NPY2R was first described in 1996; it is an appetite hormone and 
candidate gene for obesity development and control of food intake 
(24–26). Although one feeder’s NPY2R expression (F6) remained 
an outlier after normalization, this result could be attributed to 
the subject’s earlier GA, 31 5/7, compared to the other subjects 
(GA: 32 1/7 to 38 2/7).
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Similar to NPY2R, AMPK expression may also play a key regu-
latory role in feeding maturation. AMPK detects and maintains 
metabolic energy balance by promoting ATP production and 
facilitating the pathways involved in circadian rhythms of 
metabolism and feeding behavior (27, 28). Expression of these 
two protein biomarkers corresponded not only to their gene 
expression profiles previously reported but were predictive of 
the feeding status of the newborn. Thus, they have the potential 
to serve as independent and reliable biomarkers of neonatal oral 
feeding success.
Limitations of this study include the small sample size and 
the inability to detect all the biomarkers previously shown to be 
indicative of oral feeding readiness in the newborn. The assay’s 
ability to detect only biomarkers involved in hunger signal-
ing hinders its current applicability at the bedside. Biomarker 
proteins corresponding to other key developmental milestones 
required for oral feeding success including neurodevelopment, 
gastrointestinal maturation, and sensory integration will need 
to be identified before the assay will reach its full diagnostic 
potential. Nevertheless, this study is a promising first step toward 
the development of a NICU bedside device to assess oral feeding 
maturation to improve care and outcomes in this population. 
Finally, it is important to note that the assay requires only a small 
amount of neonatal saliva, which is easy to obtain and avoids 
blood collection—a cause of morbidity in neonates.
In conclusion, this pilot study is not only clinically rel-
evant because we show concordance between protein and gene 
expression but we also demonstrate that protein expression can 
be informative of oral feeding status. Thus, for these particular 
biomarkers, a rapid proteomic assay may be utilized to assess real-
time hypothalamic feeding development using neonatal saliva.
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